Clinical trials: Chronic Blepharitis
Blepharitis
Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis
The purpose of this study is to evaluate the safety and efficacy of AzaSite® ophthalmic solution, 1% on signs \& symptoms of blepharitis and tear cytokine and eyelid bacterial load levels
- Trial name
- NCT00629941
- Testing
- AzaSite®
- Where
- 2 sites in United States
- Volunteers
- 25 people
- Sponsor
- Merck Sharp & Dohme LLC
Blepharitis
A Study to Evaluate the Clinical Efficacy and Safety of Tobradex® ST Compared to Azasite® in the Treatment of Subjects With Moderate to Severe Chronic Blepharitis
The purpose of this study is to evaluate the clinical efficacy and safety of Tobradex ST compared to AzaSite in the treatment of moderate to severe chronic blepharitis.
- Trial name
- NCT01102244
- Testing
- Tobradex ST, Azasite
- Where
- United States
- Volunteers
- 122 people
- Sponsor
- Alcon Research
Chronic Blepharitis
Demodex Blepharitis Treatment Study
This is a randomized clinical trial to determine the safety and efficacy of terpinen-4-ol (T4O), the most active ingredient of tea tree oil (TTO), in eradicating ocular demodicosis (reducing ocular demodex counts and achieving…
- Trial name
- DBTS (NCT01647217)
- Testing
- Terpinen-4-ol
- Where
- United States
- Volunteers
- 17 people
- Sponsor
- BioTissue Holdings, Inc
Blepharitis
Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis
The primary objective of this study is to demonstrate the efficacy of T1225 eye drops versus placebo eye drops on the global ocular discomfort (VAS).
- Trial name
- NCT01089608
- Testing
- Azithromycin, Povidone
- Where
- France
- Volunteers
- 93 people
- Sponsor
- Laboratoires Thea